Loss of p16INK4, alone and with overexpression of osteopontin, correlates with survival of patients with spinal metastasis from hepatocellular carcinoma

Medical Oncology

Volumn 27, Issue 3, 2010, Pages 1005-1009

  Chen, Hua Jiang ^a   Xiao, Jian Ru ^a   Yuan, Wen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Osteopontin; p16INK4; Spinal metastasis

Indexed keywords

BIOLOGICAL MARKER; CD44V6 ANTIGEN; COLLAGENASE 3; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GELATINASE A; GELATINASE B; MATRILYSIN; MATRIX METALLOPROTEINASE 14; OSTEOPONTIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; PROTEIN P27; PROTEIN P53; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SPINAL CORD METASTASIS; SURVIVAL TIME; TISSUE MICROARRAY; BIOSYNTHESIS; COMPARATIVE STUDY; DNA MICROARRAY; FOLLOW UP; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; LIVER TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; PARALYSIS; PATHOLOGY; SPINAL CORD COMPRESSION; SPINAL CORD TUMOR; TIME; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P16; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOPONTIN; PARALYSIS; SPINAL CORD COMPRESSION; SPINAL NEOPLASMS; TIME FACTORS;

EID: 77956924843     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9324-7     Document Type: Article

References (23)

1. JE Kuhlman EK Fishman PK Leichner D Magid SE Order SS Siegelman 1986 Skeletal metastases from hepatoma: frequency, distribution, and radiographic features Radiology 160 1 175 178 1:STN:280:DyaL283jsVWgsg%3D%3D 3012630
2. N Okazaki M Yoshino T Yoshida S Hirohashi K Kishi Y Shimosato 1985 Bone metastasis in hepatocellular carcinoma Cancer 55 9 1991 1994 10.1002/1097-0142(19850501)55:9<1991::AID-CNCR2820550927>3.0.CO;2-F 1:STN:280:DyaL2M7ltFKntA%3D%3D 2983871 (Pubitemid 15116959)
3. M Fukutomi M Yokota H Chuman, et al. 2001 Increased incidence of bone metastases in hepatocellular carcinoma Eur J Gastroenterol Hepatol 13 9 1083 1088 10.1097/00042737-200109000-00015 1:STN:280:DC%2BD3MrhslCnuw%3D%3D 11564960 (Pubitemid 32905203)
4. CC Liaw KT Ng TJ Chen YF Liaw 1989 Hepatocellular carcinoma presenting as bone metastasis Cancer 64 8 1753 1757 10.1002/1097-0142(19891015)64:8<1753:: AID-CNCR2820640833>3.0.CO;2-N 1:STN:280:DyaK3c%2Fgt1Olug%3D%3D 2477134
5. HB El-Serag JA Marrero L Rudolph KR Reddy 2008 Diagnosis and treatment of hepatocellular carcinoma Gastroenterology 134 6 1752 1763 10.1053/j.gastro. 2008.02.090 18471552 (Pubitemid 351615415)
6. JM Llovet J Bruix 2008 Molecular targeted therapies in hepatocellular carcinoma Hepatology 48 4 1312 1327 10.1002/hep.22506 1:CAS:528: DC%2BD1cXht1Khu7zP 18821591
7. SU Kim DY Kim JY Park, et al. 2008 Hepatocellular carcinoma presenting with bone metastasis: clinical characteristics and prognostic factors J Cancer Res Clin Oncol 134 12 1377 1384 10.1007/s00432-008-0410-6 18483745
8. JL Abrahm MB Banffy MB Harris 2008 Spinal cord compression in patients with advanced metastatic cancer: "all I care about is walking and living my life" JAMA 299 8 937 946 10.1001/jama.299.8.937 1:CAS:528: DC%2BD1cXis1Cltr8%3D 18314436 (Pubitemid 351397067)
9. KA Jansson HC Bauer 2006 Survival, complications and outcome in 282 patients operated for neurological deficit due to thoracic or lumbar spinal metastases Eur Spine J 15 2 196 202 10.1007/s00586-004-0870-6 15744540
10. K Tomita N Kawahara T Kobayashi A Yoshida H Murakami T Akamaru 2001 Surgical strategy for spinal metastases Spine 26 3 298 306 10.1097/00007632- 200102010-00016 1:STN:280:DC%2BD3M3mvVOlsg%3D%3D 11224867 (Pubitemid 32144129)
11. Y Tokuhashi H Matsuzaki H Oda M Oshima J Ryu 2005 A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis Spine 30 19 2186 2191 10.1097/01.brs.0000180401.06919.a5 16205345 (Pubitemid 41429199)
12. YM der Linden SP Dijkstra EJ Vonk CA Marijnen JW Leer 2005 Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy Cancer 103 2 320 328 10.1002/cncr.20756 (Pubitemid 40129292)
13. HC Bauer R Wedin 1995 Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients Acta Orthop Scand 66 2 143 146 10.3109/17453679508995508 1:STN:280:DyaK2M3lvFGjsw%3D%3D 7740944
14. CJ Sherr 1996 Cancer cell cycles Science. 274 5293 1672 1677 10.1126/science.274.5293.1672 1:CAS:528:DyaK28XntlyktLs%3D 8939849 (Pubitemid 26414890)
15. GH Kang YH Shim HY Jung WH Kim JY Ro MG Rhyu 2001 CpG island methylation in premalignant stages of gastric carcinoma Cancer Res 61 7 2847 2851 1:CAS:528:DC%2BD3MXivFGru74%3D 11306456
16. Y Matsuda T Ichida J Matsuzawa K Sugimura H Asakura 1999 p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma Gastroenterology 116 2 394 400 10.1016/S0016-5085(99)70137-X 1:CAS:528:DyaK1MXht1Cgsbg%3D 9922321 (Pubitemid 29055363)
17. AM Hui YZ Shi X Li T Takayama M Makuuchi 2000 Loss of p16(INK4) protein, alone and together with loss of retinoblastoma protein, correlate with hepatocellular carcinoma progression Cancer Lett 154 1 93 99 10.1016/S0304-3835(00)00385-2 1:CAS:528:DC%2BD3cXivVGgsbo%3D 10799744 (Pubitemid 30229914)
18. YC Fong SC Liu CY Huang, et al. 2009 Osteopontin increases lung cancer cells migration via activation of the alphavbeta3 integrin/FAK/Akt and NF-kappaB-dependent pathway Lung Cancer 64 3 263 70 10.1016/j.lungcan.2008.09. 003 18996613
19. M Gong Z Lu G Fang J Bi X Xue 2008 A small interfering RNA targeting osteopontin as gastric cancer therapeutics Cancer Lett 272 1 148 59 10.1016/j.canlet.2008.07.004 1:CAS:528:DC%2BD1cXht1Knt77L 18694621
20. QH Ye LX Qin M Forgues, et al. 2003 Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning Nat Med 9 4 416 423 10.1038/nm843 1:CAS:528:DC%2BD3sXisVOmu7o%3D 12640447 (Pubitemid 36460075)
21. HW Pan YH Ou SY Peng, et al. 2003 Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma Cancer 98 1 119 127 10.1002/cncr.11487 1:CAS:528:DC%2BD3sXlslagur4%3D 12833464 (Pubitemid 36741134)
22. GH Yang J Fan Y Xu, et al. 2008 Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resection Oncologist 13 11 1155 1165 10.1634/theoncologist.2008-0081 1:CAS:528:DC%2BD1MXmtVGjtA%3D%3D 18997126
23. A Junaid MC Moon GE Harding P Zahradka 2007 Osteopontin localizes to the nucleus of 293 cells and associates with polo-like kinase-1 Am J Physiol Cell Physiol 292 2 C919 C926 10.1152/ajpcell.00477.2006 1:CAS:528: DC%2BD2sXjt1Gmu7Y%3D 17005603